GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » Change In Prepaid Assets

BCAX (Bicara Therapeutics) Change In Prepaid Assets : $-16.68 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bicara Therapeutics Change In Prepaid Assets?

Bicara Therapeutics's Change In Prepaid Assets for the quarter that ended in Dec. 2024 was $-16.57 Mil. It means Bicara Therapeutics's Prepaid Assets declined by $16.57 Mil from Sep. 2024 to Dec. 2024 .

Bicara Therapeutics's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was $-16.85 Mil. It means Bicara Therapeutics's Prepaid Assets declined by $16.85 Mil from Dec. 2023 to Dec. 2024 .


Bicara Therapeutics Change In Prepaid Assets Historical Data

The historical data trend for Bicara Therapeutics's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicara Therapeutics Change In Prepaid Assets Chart

Bicara Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Change In Prepaid Assets
-0.92 -0.91 -16.85

Bicara Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Change In Prepaid Assets Get a 7-Day Free Trial 0.03 -0.06 - -0.11 -16.57

Bicara Therapeutics Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bicara Therapeutics Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Bicara Therapeutics's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Bicara Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.